BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 199 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $294,313 | +13.6% | 25,637 | +24.9% | 0.05% | +4.2% |
| Q3 2022 | $259,000 | -64.7% | 20,523 | -54.5% | 0.05% | -76.2% |
| Q1 2022 | $734,000 | +56.5% | 45,155 | +33.3% | 0.20% | +59.1% |
| Q4 2021 | $469,000 | +10.6% | 33,880 | +14.9% | 0.13% | +10.4% |
| Q3 2021 | $424,000 | -55.6% | 29,490 | -51.2% | 0.12% | -56.3% |
| Q2 2021 | $955,000 | +2413.2% | 60,429 | +449.9% | 0.26% | +1778.6% |
| Q4 2019 | $38,000 | – | 10,989 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 3,846,154 | $27,230,770 | 26.28% |
| Prosight Management, LP | 2,408,135 | $17,049,596 | 5.40% |
| Kynam Capital Management, LP | 3,133,193 | $22,183,006 | 3.63% |
| Saturn V Capital Management LP | 982,458 | $6,955,803 | 2.91% |
| AlphaCentric Advisors LLC | 649,000 | $4,594,920 | 2.61% |
| TANG CAPITAL MANAGEMENT LLC | 1,800,000 | $12,744,000 | 1.80% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 791,671 | $5,605,031 | 1.70% |
| Eversept Partners, LP | 2,479,103 | $17,552,049 | 1.48% |
| DAFNA Capital Management LLC | 652,000 | $4,616,160 | 1.44% |
| Avoro Capital Advisors LLC | 11,550,000 | $81,774,000 | 1.28% |